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Abstract
Background: Intravascular large B-cell lymphoma is a rare and aggressive lymphoma with a dismal prognosis.
Synchronous intravascular large B-cell lymphoma involving gastrointestinal stromal tumor has not previously been
documented.
Case Presentation: We report a case of a 61-year-old Chinese woman who presented with high fever of unknown
origin for 20 days, and hematemesis, melena for 2 days. A computed tomography scan revealed a mass lesion
located in the anterior wall of the stomach. Surgery was performed to remove the tumor and histopathology
showed a gastrointestinal stromal tumor and a synchronous intravascular large B-cell lymphoma. The patient
refused further treatment and died 4 months after surgery.
Conclusions: To the best of our knowledge, this case represents the first report of synchronous intravascular large
B-cell lymphoma involving a gastrointestinal stromal tumor.
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Background
According to the actual WHO Classification of Tumors
of Haematopoietic and Lymphoid Tissues 2008, intravas-
cular large B-cell lymphoma (IVLBCL) belongs to the
category of mature B-cell neoplasms. It is a rare type of
extranodal large B-cell lymphoma with selective growth
of lymphoma cells within the lumina of small to inter-
mediate calibre vessels. It typically occurs in elderly per-
sons. It may be present in any organ in the absence of
lymphadenopathy with various systemic symptoms, such
as fever of unknown origin, general fatigue, marked de-
terioration in performance status, and neurological alter-
ation. The absence of typical clinical manifestations and
the aggressive behavior of IVLBCL frequently make ac-
curate and immediate diagnosis difficult. Synchronous
IVLBCL and menigioma or breast cancer has been re-
ported [1, 2].
Stomach is one of the most common sites for malignant
extranodal lymphomas. A wide variety of histological
subtypes have been reported, the most of which are
mucosa-associated lymphoid tissue(MALT) lymphoma and
diffuse large B cell lymphoma. IVLBCL in stomach has not
yet been described in the literature. Gastrointestinal stromal
tumor (GIST) is a rare mesenchymal tumor. Stomach is the
most common site of involvement of GIST. There are sev-
eral reports of concomitant gastric GIST and MALT
lymphoma in the English literature [3, 4]. To the best of
our knowledge, this case represents the first report of syn-
chronous IVLBCL involving a gastric GIST.
Case presentation
A 61-year-old woman presented with a 20-day course of
high fever of unknown origin, general fatigue, and two-
day history of hematemesis and melena, was admitted to
Guangdong General Hospital in July 2013. Physical
examination was normal. Abnormal laboratory values in-
cluded; hemoglobin: 51 g/L (reference interval 115–
155 g/L), sodium concentration: 126 mmol/L(reference
interval 136–145 mmol/L), total protein: 59 g/L(refer-
ence interval 60–80 g/L), white protein: 14 g/L(reference
interval 35–55 g/L), lactate dehydrogenase(LDH): 1233
U/L(reference interval 109–245 U/L). Activated partial
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thromboplastin time: 58 s(reference interval 30–45 s),
plasma fibrinogen(Fg): 5 g/L (reference interval 1.9–4 g/
L). Computed tomography(CT) scan of the abdomen
showed a heterogeneous mass of 2.5 cm in diameter in
the anterior wall of the stomach which was 4 cm away
from the cardia. Surgical examination showed no lymph-
adenopathy, hepatosplenomegaly or other masses in the
abdomen. Partial gastrectomy was performed.
Gross examination revealed the tumor was located in
submucosa, and had an ulcer on the surface. Histologi-
cally, the tumor was monomorphic, composed of
spindle-shaped cells. Mitotic activity ranged between 2
and 4 in 50 high power fields. Immunohistochemical
examination showed that it was positive for CD34 and
CD117, but negative for smooth-muscle actin. The Ki67
proliferation index was about 2 %. These findings were
consistent with a diagnosis of gastrointestinal stromal
tumor. Further inspection revealed multifocal, scattered
malignant cells which were exclusively within the lu-
mina of intratumoural and surrounding submucosa
blood vessels. These cells were discohesive and dis-
played a lymphoid phenotype with a rounded morph-
ology, hyperchromatic round or irregular nuclei with
prominent nucleoli, and a small amount of amphophilic
cytoplasm. Immunohistochemical examination showed
these cells were CD20, MUM1 positive, and CD10, CD3
negative. The Ki67 proliferation index was close to
100 %. The morphology and immunohistochemical
profile indicated a diagnosis of intravascular B-cell
lymphoma involving gastrointestinal stromal tumor
(Fig. 1, a-h). The patient refused further treatment and
died 4 months after the surgery.
Discussion
Our patient showed a series of nonspecific symptoms as
fever of unknown origin, general fatigue, gastrointestinal
hemorrhage, severe anemia, hypoalbuminaemia, hypona-
tremia, elevated LDH level and coagulation disorders. The
presumptive diagnosis was GIST. Histopathologically con-
firmed ulcer on the tumor might explain the symptoms of
gastrointestinal hemorrhage and anemia. Previous retro-
spective analysis of GISTs also concluded that these two
symptoms were the most common clinical presentations
for a GIST [5]. However GIST alone failed to identify the
reason for the other symptoms. Further inspection re-
vealed IVLBCL both in the tumor and gastric submucosa
around the tumor, and all the symptoms of the patient
could be explained by an IVLBCL.
Intravascular large B-cell lymphoma has two main
clinical patterns, a Western pattern characterized by
neurological or cutaneous involvement and an Asian
variant featuring multiple organ failure, hepatospleno-
megaly, pancytopenia and hemophagocytic syndrome.
However, an immediate diagnosis of IVLBCL in many
patients still remains challenging, because tumor in-
volvement can occur in any organ, even without appar-
ent clinical signs. Hematological abnormalities and
increased LDH levels commonly occur [6], but these
manifestations are also common in other hematological
diseases. Moreover, increased soluble interleukin-2(IL-2)
receptor levels have been reported in patients with
IVLBCL [6], Furthermore, soluble LR11(sLR11) levels
are significantly higher in patients with IVLBCL than in
those with other hematological malignancies, and may
represent a potentially powerful diagnostic indicator for
Fig. 1 Morphology and representative Immunohistochemical staining of the tumor. The tumor had an ulcer on the surface (a, ×20). It was composed of
spindle-shaped cells and had atypia lymphoid cells within intratumoural blood vessels (b, ×200). There were the same cells in surrounding submucosa
blood vessels (c, ×40 and d, ×400). The spindle cells were CD117 positive (e, ×200). The lymphoid cells were CD20 positive (f, ×200). The Ki67 proliferation
index of the lymphoid cells was close to 100 % (g, ×100). The lymphoid cells were CD3 positive (h, ×200)
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IVLBCL. In addition, the significant reduction of sLR11
levels upon disease remission suggests that this protein
may represent a sensitive marker for disease monitoring
[7]. But a widely used specific serum biomarker that is
directly derived from IVLBCL cells has not yet been
identified.
The organs selected by the physician for biopsy are
key to accurate diagnosis. In Asian cohorts, the most
relevant diagnostic site seems to be the bone marrow
[8]. There are several cases reported as IVLBCL coloniz-
ing preexsistent hemangiomas [9–11]. Actually we have
a case of IVLBCL involving hepatic cavernous heman-
gioma(unpublished case). Skin lesions including telangi-
ectasia, senile angioma-like eruption, purpuric plaques
and indurated erythematous plaques were present in one
third of patients. An early diaganosis could be made by
biopsy of these lesions [12–14]. Even in patients without
skin lesions, the usefulness of random skin biopsy (RSB)
for the diagnosis of IVLBCL has been suggested [15–18].
Asada et al. recommended deep biopsy involving sub-
cutaneous fat because the affected vessels were located
in the deep dermis or subcutaneous adipose tissue in
cases [18].
In pathological examination, neoplastic cells of
IVLBCL are large lymphoid cells with prominent nucle-
oli and express B-cell-associated antigens like CD19,
CD20, CD22 and CD79a, and almost all are CD10 nega-
tive cases showing a non-germinal center pattern with
IRF4/MUM1 positivity. They are negative for T cell
markers like CD3, CD5. Factors underlying the exclu-
sively intravascular location of the tumor cells remain
enigmatic but could be related to the absence of certain
endothelial adhesion proteins that has been demon-
strated in IVLBCL, such as CD29 and CD54 [19].
Clinical outcomes of IVLBCL were extremely dismal
before the rituximab era. However the recent develop-
ment of rituximab-containing chemotherapy has im-
proved the outcome of IVLBCL: a retrospective analysis
of Western and Asian cohorts reported 3-year overall
survival rates of 81 and 60 % respectively [20, 21]. But
our patient refused further treatment because she could
not afford the expensive treatment costs, and died
4 months after surgery.
Conclusion
In conclusion, we describe the first case of synchronous
ILBCL and GIST of the stomach, the occurrence of a
GIST in this particular case could be considered fortuit-
ous. We want to emphasize that nonspecific clinical find-
ings as fever and progressive deteriorated general
conditions in combination with elevated LDH and low al-
bumin levels should should raise the suspicion for lymph-
oma in general and after exclusion of these even for rare
lymphoma like IVLBCL. Absence of lymphoadenomegaly,
hepatosplenomegaly, bone marrow involvement, or other
solid neoformations does not rule out a lymphoprolifera-
tive disorder.
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